Top Analyst Upgrades and Downgrades: Amazon, Blackstone, FireEye, Myriad Genetics, Visa, CBOE, Hershey, Vail and Many More

December 8, 2015 by Jon C. Ogg

Stocks were looking to extend losses on Tuesday after a weak showing on Monday. The trend that has lasted for over four years now is that investors have found myriad reasons to buy the pullbacks. 24/7 Wall St. reviews dozens of analyst research reports each day. The goal is to find new investing and trading ideas for our readers. Some of the daily analyst reports cover stocks to buy, and others cover stocks to sell or avoid.

These are this Tuesday’s top analyst upgrades, downgrades and initiations.

Amazon.com Inc. (NASDAQ: AMZN) was started as Overweight with an $800 price target at KeyBanc Capital Markets. Amazon closed at $669.83, has a consensus analyst price target of $285.25 and has a 52-week trading range of $285.25 to $684.82.

Blackstone Group L.P. (NYSE: BX) was downgraded to Neutral from Buy at Bank of America Merrill Lynch, and the price target was cut to $33 from $40 (versus a $30.41 prior close). The stock has a 52-week range of $28.56 to $44.43.

FireEye Inc. (NASDAQ: FEYE) was raised to Buy from Neutral and the price target was raised to $35 from $31 (versus a $20.19 close) at Citigroup. It has a consensus price target of $32.24 and a 52-week range of $19.76 to $55.33. Keep in mind that FireEye’s 52-week low was set just on Monday.

Myriad Genetics Inc. (NASDAQ: MYGN) was raised to Neutral from Sell and the price target was raised to $40 from $31 at Goldman Sachs. Myriad closed at $42.76, has a consensus target of $40.50 and has a 52-week range of $30.30 to $46.24.

Visa Inc. (NYSE: V) was reiterated as Outperform and the price target was raised to $95 from $85 at Keefe Bruyette & Woods. Shares closed at $79.55. The consensus price target is $86.07 and the 52-week range is $60.00 to $81.01.


Other key analyst upgrades, downgrades and initiations seen on Tuesday were in the following:

CBOE Holdings Inc. (NASDAQ: CBOE) was downgraded to Underweight from Equal Weight and the price target was cut to $59 from $61 at Barclays. CBOE closed at $69.26, has a consensus price target of $64.92, and has a 52-week range of $55.04 to $72.53.

Dean Foods Co. (NYSE: DF) was downgraded to Underweight from Equal Weight and the price target was cut to $17 from $19 at Morgan Stanley. The stock closed at $18.68 and has a consensus price target of $20.38 and a 52-week range of $14.56 to $19.74.

Franklin Resources Inc. (NYSE: BEN) was downgraded to Underweight from Equal Weight and the price target was cut to $36 from $39 at Barclays. It closed at $40.82, has a consensus price target of $42.15 and has a 52-week range of $36.10 to $58.84.

Hershey Co. (NYSE: HSY) was raised to Buy from Hold with a $96 price target at Argus. Hershey closed at $87.14. The consensus analyst price target is $93.00. The 52-week range is $82.41 to $111.35.

Instructure Inc. (NYSE: INST) was started as Buy at both Goldman Sachs and at Jefferies. Oppenheimer started it with an Outperform rating.

Kellogg Co. (NYSE: K) was raised to Equal Weight from Underweight and the price target was raised to $69 from $65 at Morgan Stanley. Kellogg closed at $70.51, has a consensus price target of $70.00 and has a 52-week range of $61.13 to $72.34.

Keurig Green Mountain Inc. (NASDAQ: GMCR) was downgraded to Market Perform from Outperform at William Blair.

Laboratory Corp. of America Holdings (NYSE: LH) was downgraded to Neutral from Buy at Goldman Sachs.


pdvWireless Inc. (NASDAQ: PDVW) was started as Buy with a $79 price target at Canaccord Genuity. This one closed at $24.43, with a consensus analyst price target of $68.67 and a 52-week range of $22.27 to $56.00.

Vail Resorts Inc. (NYSE: MTN) was raised to Buy from Neutral at Goldman Sachs, but it was downgraded to Market Perform from Outperform at JMP Securities. Janney Capital markets reiterated its Buy rating. Vail Resorts closed at $125.58 and has a consensus target price before the changes of $126.22.

If you missed out on Monday’s top analyst upgrades and downgrades, they were in shares of Abbott Labs, Bluebird Bio, Chipotle, Eli Lilly, Ferrari, Wells Fargo and over a dozen more companies.